Alpine Global Management, LLC Abbott Laboratories Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $1.25 Million - $1.39 Million	12,363 Added 68.19%	30,494 $3.17 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.99 Million - $2.19 Million	18,131 New	18,131 $2.06 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $5.25 Million - $5.72 Million	-50,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $4.22 Million - $5.12 Million	46,038 Added 1161.99%	50,000 $5.44 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $303,370 - $388,276	3,962 New	3,962 $362,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.